Markets

Fundamentals in Focus for Ambev S.A. (ABEV)

Ambev S.A. (NYSE:ABEV) seems to be forming a pattern of major movements, providing only some crumbs of outlook for market participants trying to figure out its next move. Now trading with a market value of 91.11B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Ambev S.A. (NYSE:ABEV) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For ABEV, the company currently has 10.35 billion of cash on the books, which is offset by 1.32 billion in current liabilities. The trend over time is important to note. In this case, the company’s debt has been falling. The company also has 87.78 billion in total assets, balanced by 39.8 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Ambev S.A. (ABEV) saw 7.74 billion in free cash flow last quarter, representing a quarterly net change in cash of 2.01 billion. Perhaps most importantly where cash movements are concerned, the company saw about 8.9 billion in net operating cash flow.

Ambev S.A. (NYSE:ABEV) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 15.03 billion in total revenues. That represents a quarterly year/year change in revenues of 0.14 in sequential terms, the ABEV saw sales decline by 0.32.



But what about the bottom line? After all, that’s what really matters in the end. Ambev S.A. (ABEV) is intriguing when broken down to its core data. The cost of selling goods last quarter was 5.35 billion, yielding a gross basic income of 9.68 billion. For shareholders, given the total diluted outstanding shares of 15.84 billion, this means overall earnings per share of 0.20. Note, this compares with a consensus analyst forecast of 0.07 in earnings per share for its next fiscal quarterly report.

Is Ambev S.A. (NYSE:ABEV) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 0.31 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 21.50. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Ambev S.A..

Previous ArticleNext Article

Related Post

New York Community Bancorp, Inc. (NYCB): Interesti... New York Community Bancorp, Inc. (NYSE:NYCB) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market va...
Revisit the buy and-hold case for Neos Therapeutic... Neos Therapeutics, Inc. (NASDAQ:NEOS) fell by -5.43% in Monday’s trading session from $9.20 to $8.70 The stock price went upward in 5 of the last 10 d...
Critical Comparison: GameStop Corp. (GME) vs. Appl... GameStop Corp. (NYSE:GME) and Appliance Recycling Centers of America, Inc. (NASDAQ:ARCI) are the two most active stocks in the Electronics Stores indu...
Checking Out the Fundamental Data for Alibaba Grou... Alibaba Group Holding Limited (NYSE:BABA) is an interesting stock at present. Now trading with a market value of 446.40B, the company has a mix of cat...
Dissecting the Numbers for Inovio Pharmaceuticals,... Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) are the two most active stocks in the Biotechnology indust...